Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
NOT_YET_RECRUITING
NCT06610825
Castrate Resistant Prostate Cancer Enhertu Therapy
60
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Prostate Cancer Metastatic
Prostate Cancer
CRPC
COMPLETED
NCT03248492
A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)
253
Enrollment(s)
99
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
NOT_YET_RECRUITING
NCT06588595
The Switching Antiplatelet-9 (SWAP-9) Study
90
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)
RECRUITING
NCT06525298
EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors
144
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Advanced Solid Tumor
Homologous Recombination Deficiency
HRR Deficiency
ACTIVE_NOT_RECRUITING
NCT05804747
A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation
1,204
Enrollment(s)
33
Study location(s)
OBSERVATIONAL (None)
Atrial Fibrillation
RECRUITING
NCT05744375
Trastuzumab Deruxtecan in First-line HER2-positive Locally Advanced/MBC Patients Resistant to Trastuzumab+Pertuzumab
41
Enrollment(s)
19
Study location(s)
INTERVENTIONAL (PHASE2)
Locally Advanced Breast Cancer
Metastatic Breast Cancer
COMPLETED
NCT05419583
Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction
60
Enrollment(s)
2
Study location(s)
INTERVENTIONAL (NA)
Myocardial Infarction Type 2
TERMINATED
NCT03735875
Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myeloid Leukemia
8
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Acute Myeloid Leukemia With FLT3/ITD Mutation
Recurrent Acute Myeloid Leukemia
Refractory Acute Leukemia
11
12
13
14
15